Factors Associated with Long‐Term Antibody Production Induced by Hepatitis B Vaccine in Patients Undergoing Hemodialysis: A Retrospective Cohort Study

Abstract

Long-term seroprevalence induced by hepatitis B vaccine was low in our patients 12 and 24 months after vaccination. These results were comparable to previously reported long-term results. Larger, prospective studies would be needed to confirm the finding that patients with diabetes had superior hepatitis B vaccine-induced antibody production at 24 months.